SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-10-279572
Filing Date
2010-12-14
Accepted
2010-12-13 18:10:09
Documents
4
Period of Report
2010-12-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 20428
2 AMENDMENT NO. 1 TO STRATEGIC ALLIANCE AGREEMENT dex991.htm EX-99.1 27608
3 AMENDMENT NO. 1 TO 2010 STOCK INCENTIVE PLAN dex992.htm EX-99.2 5106
4 GRAPHIC g127663g07h76.jpg GRAPHIC 33069
  Complete submission text file 0001193125-10-279572.txt   100744
Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 6174531000
INFINITY PHARMACEUTICALS, INC. (Filer) CIK: 0001113148 (see all company filings)

IRS No.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-31141 | Film No.: 101248974
SIC: 2834 Pharmaceutical Preparations